Selective Bcl-2 inhibition promotes hematopoietic chimerism and allograft tolerance without myelosuppression in nonhuman primates
Hajime Sasaki(Sapporo City General Hospital), Tatsuo Kawai(Harvard University), Ahmad Karadagi(Karolinska University Hospital), Robert B. Colvin(Harvard University), Susan Raju Paul(Massachusetts General Hospital), Samuel I. Schwartz(Massachusetts General Hospital), Tetsu Oura(Harvard University), Toshihide Tomosugi(Harvard University), Takayuki Hirose(Harvard University), Grace Lassiter(Massachusetts General Hospital), Thomas R. Spitzer(Harvard University), Patrick M. Reeves(Harvard University), Masatoshi Matsunami(Massachusetts General Hospital), Pietro E. Cippà(University of Basel), Thomas Fehr(University Hospital of Zurich), I. Hanekamp(Massachusetts General Hospital), Ryo Otsuka(Hokkaido University), Dávid Ma(St Vincent's Hospital Sydney), Hang Lee(Massachusetts General Hospital), A. Dehnadi(Harvard University), A. Benedict Cosimi(Massachusetts General Hospital), Ivy A. Rosales(Harvard University)
Cited by 19
Related Papers
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
|The Journal of Clinical Endocrinology & Metabolism|2007|1.6k